Trial NCT02376699

View at ClinicalTrials.gov 
Org. Study IDs: SGNS40-001
Secondary IDs: PN 863

Last trial update was posted on 2023-05-01

MeSH Interventions

Gemcitabine Paclitaxel Pembrolizumab

MeSH Conditions

Carcinoma Carcinoma, Non-Small-Cell Lung Carcinoma, Squamous Cell Head and Neck Neoplasms Hodgkin Disease Lung Neoplasms Lymphoma Lymphoma, B-Cell Lymphoma, Follicular Lymphoma, Large B-Cell, Diffuse Lymphoma, Non-Hodgkin Neoplasm Metastasis Neoplasms Neoplasms, Squamous Cell Squamous Cell Carcinoma of Head and Neck

Other Conditions

Melanoma Neoplasms, Head and Neck Non-Small Cell Lung Cancer Non-Small Cell Lung Cancer Metastatic Non-small Cell Carcinoma Pancreatic Adenocarcinoma Squamous Cell Cancer Squamous Cell Carcinoma Squamous Cell Carcinoma of the Head and Neck Squamous Cell Neoplasm

Stopping Reasons

Study closed due to portfolio prioritization

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID